4//SEC Filing
Roth David 4
Accession 0001209191-23-044218
CIK 0001556263other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:21 PM ET
Size
4.9 KB
Accession
0001209191-23-044218
Insider Transaction Report
Form 4
Roth David
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-07-31$3.95/sh−7,348$29,025→ 0 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was effected pursuant to a trading plan adopted on March 27, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001599014
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:21 PM ET
- Size
- 4.9 KB